Literature DB >> 7790070

Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier.

J A Chabalgoity1, B Villareal-Ramos, C M Khan, S N Chatfield, R D de Hormaeche, C E Hormaeche.   

Abstract

We have previously described a new system for the delivery of recombinant antigens in live Salmonella vaccines as genetic fusions to the C terminus of fragment C of tetanus toxin (TetC) driven by the anaerobically inducible nirB promoter. It has been reported that preimmunization with tetanus toxoid (TT) can suppress the antibody response to peptides chemically coupled to TT (epitope-specific suppression) in both animals and humans, which could interfere with efficacy of the Salmonella-TetC delivery system. We report that preimmunization of BALB/c mice with TT in alum did not suppress the response to either of two protective antigens of Schistosoma mansoni, the full-length S. mansoni P28 glutathione S-transferase (P28) and a construct consisting of eight tandem copies of the protective peptide comprising amino acids 115 to 131 of P28. The guest antigens were expressed in the aroA Salmonella typhimurium SL3261 vaccine strain as fusions to TetC. Preimmunization with TT 10 weeks before administration of the recombinant salmonellae did not alter the antibody response to the full-length P28, whereas the response to the peptide comprising amino acids 115 to 131 was increased by preimmunization with TT, with the increase seen mainly in the immunoglobulin G1 isotype. The antitetanus response was increased by preimmunization with TT in all groups receiving salmonellae expressing TetC. The results could be important when one is considering the use of the Salmonella-TetC delivery system in populations preimmunized with TT.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790070      PMCID: PMC173343          DOI: 10.1128/iai.63.7.2564-2569.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Epitopic suppression in synthetic vaccine models: analysis of the effector mechanisms.

Authors:  M P Schutze; C Leclerc; F R Vogel; L Chedid
Journal:  Cell Immunol       Date:  1987-01       Impact factor: 4.868

2.  Protection against experimental salmonellosis in mice and sheep by immunisation with aromatic-dependent Salmonella typhimurium.

Authors:  T K Mukkur; G H McDowell; B A Stocker; A K Lascelles
Journal:  J Med Microbiol       Date:  1987-08       Impact factor: 2.472

3.  Lack of immune response gene control for induction of epitope-specific suppression by TGAL antigen.

Authors:  L A Herzenberg; T Tokuhisa; K Hayakawa; L A Herzenberg
Journal:  Nature       Date:  1982-01-28       Impact factor: 49.962

4.  Carrier-priming leads to hapten-specific suppression.

Authors:  L A Herzenberg; T Tokuhisa; L A Herzenberg
Journal:  Nature       Date:  1980-06-26       Impact factor: 49.962

5.  Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves.

Authors:  B P Smith; M Reina-Guerra; S K Hoiseth; B A Stocker; F Habasha; E Johnson; F Merritt
Journal:  Am J Vet Res       Date:  1984-01       Impact factor: 1.156

6.  Salmonella typhimurium infection in calves: specific immune reactivity against O-antigenic polysaccharide detectable in in vitro assays.

Authors:  J A Robertsson; C Fossum; S B Svenson; A A Lindberg
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

7.  Carrier-induced epitopic suppression, a major issue for future synthetic vaccines.

Authors:  M P Schutze; C Leclerc; M Jolivet; F Audibert; L Chedid
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

8.  Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.

Authors:  D A Herrington; D F Clyde; G Losonsky; M Cortesia; J R Murphy; J Davis; S Baqar; A M Felix; E P Heimer; D Gillessen
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

9.  Construction, expression, and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide 115-131 of the P28 glutathione S-transferase expressed as C-terminal fusions to tetanus toxin fragment C in a live aro-attenuated vaccine strain of Salmonella.

Authors:  C M Khan; B Villarreal-Ramos; R J Pierce; R Demarco de Hormaeche; H McNeill; T Ali; S Chatfield; A Capron; G Dougan; C E Hormaeche
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

10.  Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses.

Authors:  L A Herzenberg; T Tokuhisa
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  3 in total

1.  Expression and immunogenicity of an Echinococcus granulosus fatty acid-binding protein in live attenuated Salmonella vaccine strains.

Authors:  J A Chabalgoity; J A Harrison; A Esteves; R Demarco de Hormaeche; R Ehrlich; C M Khan; C E Hormaeche
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

2.  Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C.

Authors:  M Roberts; A Bacon; J Li; S Chatfield
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

3.  Diminished amyloid-beta burden in Tg2576 mice following a prophylactic oral immunization with a salmonella-based amyloid-beta derivative vaccine.

Authors:  Allal Boutajangout; Fernando Goni; Elin Knudsen; Fernanda Schreiber; Ayodeji Asuni; David Quartermain; Blas Frangione; Alejandro Chabalgoity; Thomas Wisniewski; Einar M Sigurdsson
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.